The promoters and promoter group of the drug firm have expressed their intention to not participate in the buyback, the firm said in a filing to BSE.
So far in 2019, the stock has slipped 34 per cent from a level of Rs 684 per share as against a 8 per cent rise in the S&P BSE Sensex. It touched an all-time high of Rs 896 on March 14, 2018.
got listed at the exchanges on June 29, 2017 and had raised Rs 1,741-crore through initial public offering (IPO) at issue price of Rs 603 per share.
At 10:02 am, the stock was quoting at 7 per cent lower at Rs 458, against a 0.15 per cent decline in the benchmark index. A combined 65,817 shares have changed hands on the counter on the NSE and BSE so far.